ContraFect Announces ASM Microbe 2019 Outstanding Abstract Award and Presentation of New Data


You May Also Like

Checkpoint Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), ...

resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition

BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company ...